» Articles » PMID: 21746961

The Src Family Kinase Fgr is Critical for Activation of Mast Cells and IgE-mediated Anaphylaxis in Mice

Overview
Journal J Immunol
Date 2011 Jul 13
PMID 21746961
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Mast cells are critical for various allergic disorders. Mast cells express Src family kinases, which relay positive and negative regulatory signals by Ag. Lyn, for example, initiates activating signaling events, but it also induces inhibitory signals. Fyn and Hck are reported to be positive regulators, but little is known about the roles of other Src kinases, including Fgr, in mast cells. In this study, we define the role of Fgr. Endogenous Fgr associates with FcεRI and promotes phosphorylation of Syk, Syk substrates, which include linkers for activation of T cells, SLP76, and Gab2, and downstream targets such as Akt and the MAPKs in Ag-stimulated mast cells. As a consequence, Fgr positively regulates degranulation, production of eicosanoids, and cytokines. Fgr and Fyn appeared to act in concert, as phosphorylation of Syk and degranulation are enhanced by overexpression of Fgr and further augmented by overexpression of Fyn but are suppressed by overexpression of Lyn. Moreover, knockdown of Fgr by small interfering RNAs (siRNAs) further suppressed degranulation in Fyn-deficient bone marrow-derived mast cells. Overexpression of Fyn or Fgr restored phosphorylation of Syk and partially restored degranulation in Fyn-deficient cells. Additionally, knockdown of Fgr by siRNAs inhibited association of Syk with FcεRIγ as well as the tyrosine phosphorylation of FcεRIγ. Of note, the injection of Fgr siRNAs diminished the protein level of Fgr in mice and simultaneously inhibited IgE-mediated anaphylaxis. In conclusion, Fgr positively regulates mast cell through activation of Syk. These findings help clarify the interplay among Src family kinases and identify Fgr as a potential therapeutic target for allergic diseases.

Citing Articles

Multi-omics analysis to reveal the synergistic mechanism underlying the multiple ingredients of extract on rheumatoid arthritis through the PI3K/Akt signaling pathway.

Chen J, Zhang A, Nie A, Zuo X, Zhang L, Jiao Y Front Pharmacol. 2024; 15:1447283.

PMID: 39221139 PMC: 11361992. DOI: 10.3389/fphar.2024.1447283.


AT9283, 1-Cyclopropyl-3-(3-(5-(Morpholinomethyl)-1H-Benzo[d]Imidazole-2-yl)-1H-Pyrazol-4-yl) Urea, Inhibits Syk to Suppress Mast Cell-Mediated Allergic Response.

Kim S, Choi M, Min K, Jo M, Kim J, Kim H Biomol Ther (Seoul). 2022; 30(6):520-528.

PMID: 36305292 PMC: 9622312. DOI: 10.4062/biomolther.2022.042.


Combination of midostaurin and ATRA exerts dose-dependent dual effects on acute myeloid leukemia cells with wild type FLT3.

Lu H, Weng X, Sheng Y, Wu J, Xi H, Cai X BMC Cancer. 2022; 22(1):749.

PMID: 35810308 PMC: 9270826. DOI: 10.1186/s12885-022-09828-2.


Lactic Acid Bacteria Fermented (GRC-SC11) Suppresses IgE Mediated Mast Cell Activation and Type I Hypersensitive Allergic Murine Model.

Phull A, Dhong K, Park H Nutrients. 2021; 13(11).

PMID: 34836105 PMC: 8618942. DOI: 10.3390/nu13113849.


Assessment of changes in genetic transcriptome in nasal epithelial cells exposed to ozone-aged black carbon and pollen allergen by high-throughput transcriptomics.

Ouyang Y, Li Y, Xu Z, An Y, Zhang L Allergy Asthma Clin Immunol. 2021; 17(1):52.

PMID: 34022950 PMC: 8141196. DOI: 10.1186/s13223-021-00553-2.


References
1.
Kawabuchi M, Satomi Y, Takao T, Shimonishi Y, Nada S, Nagai K . Transmembrane phosphoprotein Cbp regulates the activities of Src-family tyrosine kinases. Nature. 2000; 404(6781):999-1003. DOI: 10.1038/35010121. View

2.
Siraganian R, Zhang J, Suzuki K, Sada K . Protein tyrosine kinase Syk in mast cell signaling. Mol Immunol. 2002; 38(16-18):1229-33. DOI: 10.1016/s0161-5890(02)00068-8. View

3.
Wershil B, Mekori Y, Murakami T, Galli S . 125I-fibrin deposition in IgE-dependent immediate hypersensitivity reactions in mouse skin. Demonstration of the role of mast cells using genetically mast cell-deficient mice locally reconstituted with cultured mast cells. J Immunol. 1987; 139(8):2605-14. View

4.
Xu Y, Harder K, Huntington N, Hibbs M, Tarlinton D . Lyn tyrosine kinase: accentuating the positive and the negative. Immunity. 2005; 22(1):9-18. DOI: 10.1016/j.immuni.2004.12.004. View

5.
Hong H, Kitaura J, Xiao W, Horejsi V, Ra C, Lowell C . The Src family kinase Hck regulates mast cell activation by suppressing an inhibitory Src family kinase Lyn. Blood. 2007; 110(7):2511-9. PMC: 1988937. DOI: 10.1182/blood-2007-01-066092. View